Skip to main content

Closed

GENB: Generate Biomedicines, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-737.0%

ROIC-89.4%

Financially safe

Stretched

Debt / equity-0.11×

Interest coverage-206.9×

Current ratio2.85×

Generate Biomedicines, Inc.

GENBNASDAQ Global Market·USD·Closed

Generate Biomedicines, Inc.

GENBNASDAQ·USD·Closed

$14.00

−0.21%

$14.00

−$0.03 (0.21%)

52W Range

42thpctl

Volume

0.39×avg

Mkt Cap

1.79BUSD

P/E

-2.8TTM

Div Yield

–ann

52W Range

42thpctl

Volume

0.39×avg

Market Cap

1.79BUSD

P/E Ratio

-2.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings